|
Volumn 31, Issue 11, 2010, Pages 1248-1249
|
Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLARITHROMYCIN;
LEVOFLOXACIN;
METRONIDAZOLE;
TINIDAZOLE;
ANTIBIOTIC RESISTANCE;
BELGIUM;
BRAZIL;
DRUG COST;
DRUG HALF LIFE;
DRUG TREATMENT FAILURE;
ERADICATION THERAPY;
GERMANY;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HONG KONG;
HUMAN;
ITALY;
JAPAN;
KOREA;
LETTER;
PRIORITY JOURNAL;
SPAIN;
ADOLESCENT;
ADULT;
AGED;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
FEMALE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
METRONIDAZOLE;
MIDDLE AGED;
OFLOXACIN;
TINIDAZOLE;
YOUNG ADULT;
|
EID: 77951780215
PISSN: 02692813
EISSN: 13652036
Source Type: Journal
DOI: 10.1111/j.1365-2036.2010.04286.x Document Type: Letter |
Times cited : (7)
|
References (5)
|